Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7134830
Reference Type
Journal Article
Title
Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network
Author(s)
Visweswaran, S; Becich, MJ; D'Itri, VS; Sendro, ER; Macfadden, D; Anderson, NR; Allen, KA; Ranganathan, D; Murphy, SN; Morrato, EH; Pincus, HA; Toto, R; Firestein, GS; Nadler, LM; Reis, SE; ,
Year
2018
Language
English
PMID
30474072
DOI
10.1093/jamiaopen/ooy033
Abstract
The Accrual to Clinical Trials (ACT) network is a federated network of sites from the National Clinical and Translational Science Award (CTSA) Consortium that has been created to significantly increase participant accrual to multi-site clinical trials. The ACT network represents an unprecedented collaboration among diverse CTSA sites. The network has created governance and regulatory frameworks and a common data model to harmonize electronic health record (EHR) data, and deployed a set of Informatics for Integrating Biology and the Bedside (i2b2) data repositories that are linked by the Shared Health Research Information Network (SHRINE) platform. It provides investigators the ability to query the network in real time and to obtain aggregate counts of patients who meet clinical trial inclusion and exclusion criteria from sites across the United States. The ACT network infrastructure provides a basis for cohort discovery and for developing new informatics tools to identify and recruit participants for multi-site clinical trials.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity